Teva, Eli Lilly Call Off Infringement Suit Over Migraine Drug
Teva Pharmaceuticals International GmbH has moved in Massachusetts federal court to permanently drop an infringement case against Eli Lilly and Co. over a migraine drug — an action taken after the...To view the full article, register now.
Already a subscriber? Click here to view full article